Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.24 trillion, total revenue of $4.6 trillion and a weighted average PE ratio of 45.63.
Market Cap
9.24T
Revenue
4.6T
Profits
202.6B
PE Ratio
45.63
Profit Margin
4.41%
Dividend Yield
0.39%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 1.93% | 2,379,982 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 642.79B | 0.29% | 10,497,912 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 465.02B | 2.45% | 7,060,443 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 389.40B | 2.67% | 5,919,972 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 325.57B | 0.81% | 10,265,058 | 65.77B |
| 6 | NVS | Novartis AG | 303.28B | 2.40% | 1,689,946 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 267.01B | 1.67% | 4,740,936 | 61.37B |
| 8 | NVO | Novo Nordisk A/S | 226.16B | 2.60% | 9,521,674 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 214.21B | 3.02% | 3,034,471 | 46.34B |
| 10 | AMGN | Amgen Inc. | 212.16B | 4.48% | 3,414,443 | 37.22B |
| 11 | ABT | Abbott Laboratories | 186.84B | 2.66% | 12,666,032 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 166.77B | 2.91% | 6,947,168 | 29.74B |
| 13 | PFE | Pfizer Inc. | 143.91B | 2.35% | 49,942,744 | 63.32B |
| 14 | DHR | Danaher Corporation | 139.93B | 1.30% | 9,363,915 | 25.11B |
| 15 | CVS | CVS Health Corporation | 139.51B | 2.12% | 6,682,269 | 405.62B |
| 16 | SYK | Stryker Corporation | 132.87B | 2.93% | 2,751,776 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.88B | 1.66% | 15,143,333 | 48.48B |
| 18 | ISRG | Intuitive Surgical, Inc. | 127.82B | 1.39% | 4,088,169 | 11.03B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 124.46B | 2.38% | 1,700,872 | 12.22B |
| 20 | MDT | Medtronic plc | 111.21B | 3.16% | 14,505,134 | 36.36B |
| 21 | SNY | Sanofi | 108.73B | 3.50% | 2,850,036 | 54.60B |
| 22 | GSK | GSK plc | 108.16B | 3.33% | 8,292,872 | 44.05B |
| 23 | MCK | McKesson Corporation | 104.14B | 4.64% | 1,602,028 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 92.77B | 7.33% | 2,926,022 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.65B | 1.95% | 1,758,625 | 201.11B |
| 26 | CI | The Cigna Group | 79.64B | 3.45% | 1,858,953 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 70.73B | 4.20% | 900,409 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 68.46B | 1.21% | 26,905,671 | 20.61B |
| 29 | COR | Cencora, Inc. | 62.18B | 2.71% | 1,237,828 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.03B | 0.46% | 3,756,901 | 28.34B |
| 31 | ARGX | argenx SE | 55.01B | -1.87% | 293,959 | 5.32B |
| 32 | CAH | Cardinal Health, Inc. | 54.46B | 1.38% | 2,652,244 | 250.74B |
| 33 | MDLN | Medline Inc. | 53.22B | 2.04% | 8,058,471 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 48.18B | 0.77% | 5,606,870 | 6.51B |
| 35 | HUM | Humana Inc. | 46.67B | 1.98% | 2,253,982 | 137.20B |
| 36 | BDX | Becton, Dickinson and Company | 45.83B | 4.67% | 2,693,358 | 22.23B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 44.93B | 2.40% | 446,309 | 4.45B |
| 38 | HLN | Haleon plc | 44.64B | 3.32% | 16,914,021 | 14.85B |
| 39 | IQV | IQVIA Holdings Inc. | 40.55B | 13.94% | 5,096,703 | 16.98B |
| 40 | A | Agilent Technologies, Inc. | 39.69B | 1.92% | 2,277,366 | 7.23B |
| 41 | RVMD | Revolution Medicines, Inc. | 39.09B | -2.24% | 2,401,465 | - |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.51B | 3.60% | 1,437,745 | 4.29B |
| 43 | WAT | Waters Corporation | 37.69B | 3.42% | 919,312 | 3.77B |
| 44 | TEVA | Teva Pharmaceutical Industries Limited | 36.88B | 1.90% | 5,056,278 | 17.35B |
| 45 | ONC | BeOne Medicines AG | 36.74B | 1.40% | 257,490 | 5.74B |
| 46 | NTRA | Natera, Inc. | 36.12B | -2.25% | 1,024,690 | 2.50B |
| 47 | RPRX | Royalty Pharma plc | 34.53B | 2.11% | 3,139,110 | 2.44B |
| 48 | ALC | Alcon Inc. | 33.72B | 2.72% | 3,179,121 | 10.63B |
| 49 | VEEV | Veeva Systems Inc. | 32.68B | 3.47% | 1,692,117 | 3.32B |
| 50 | ZTS | Zoetis Inc. | 32.49B | 0.77% | 6,322,624 | 9.53B |
| 51 | CNC | Centene Corporation | 31.57B | -0.27% | 12,246,817 | 180.30B |
| 52 | BIIB | Biogen Inc. | 30.36B | 2.73% | 1,832,180 | 9.94B |
| 53 | RMD | ResMed Inc. | 30.14B | 2.90% | 1,137,282 | 5.54B |
| 54 | ILMN | Illumina, Inc. | 29.20B | 1.85% | 2,112,806 | 4.39B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 29.16B | 4.89% | 7,990,401 | 20.98B |
| 56 | DXCM | DexCom, Inc. | 28.88B | 2.02% | 4,120,277 | 4.82B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.06B | 3.90% | 202,394 | 4.09B |
| 58 | DGX | Quest Diagnostics Incorporated | 26.04B | 1.77% | 1,611,965 | 11.56B |
| 59 | INCY | Incyte Corporation | 25.96B | 9.30% | 5,921,516 | 5.82B |
| 60 | LH | Labcorp Holdings Inc. | 25.77B | 4.34% | 1,136,225 | 14.14B |
| 61 | PHG | Koninklijke Philips N.V. | 24.96B | 2.12% | 3,136,000 | 20.18B |
| 62 | ROIV | Roivant Sciences Ltd. | 24.34B | -2.53% | 4,400,256 | 8.26M |
| 63 | WST | West Pharmaceutical Services, Inc. | 23.72B | 1.74% | 876,498 | 3.33B |
| 64 | BNTX | BioNTech SE | 23.38B | 1.49% | 679,284 | 3.23B |
| 65 | THC | Tenet Healthcare Corporation | 22.62B | 7.92% | 1,831,522 | 21.81B |
| 66 | INSM | Insmed Incorporated | 22.57B | -0.57% | 1,945,720 | 819.56M |
| 67 | STE | STERIS plc | 22.45B | 5.47% | 873,327 | 5.94B |
| 68 | UTHR | United Therapeutics Corporation | 22.23B | -0.82% | 446,331 | 3.17B |
| 69 | MRNA | Moderna, Inc. | 22.14B | 0.31% | 5,557,787 | 2.23B |
| 70 | VTRS | Viatris Inc. | 20.80B | 1.25% | 9,602,173 | 14.56B |
| 71 | GH | Guardant Health, Inc. | 19.04B | -1.27% | 1,579,712 | 1.08B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.52B | 4.00% | 3,737,133 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 18.38B | 3.64% | 1,333,545 | 3.10B |
| 74 | GMAB | Genmab A/S | 17.86B | 0.69% | 2,212,644 | 3.90B |
| 75 | ASND | Ascendis Pharma A/S | 16.77B | 0.40% | 578,554 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.77B | 1.70% | 2,180,315 | 579.96M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.14B | 0.58% | 945,213 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.94B | -3.12% | 744,205 | 2.78B |
| 79 | DVA | DaVita Inc. | 15.37B | 1.33% | 650,567 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 15.10B | 0.67% | 1,811,507 | 13.65B |
| 81 | SOLV | Solventum Corporation | 14.92B | 7.08% | 2,313,867 | 8.26B |
| 82 | EXEL | Exelixis, Inc. | 14.20B | 1.25% | 2,489,470 | 2.38B |
| 83 | COO | The Cooper Companies, Inc. | 14.05B | 2.52% | 1,772,810 | 4.23B |
| 84 | ICLR | ICON Public Limited Company | 13.81B | 6.79% | 1,790,431 | 8.27B |
| 85 | SNN | Smith & Nephew plc | 13.43B | 4.63% | 3,409,286 | 6.16B |
| 86 | FMS | Fresenius Medical Care AG | 13.08B | -0.48% | 1,266,427 | 22.32B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.75B | 0.43% | 4,279,441 | 4.89B |
| 88 | BAX | Baxter International Inc. | 12.59B | 4.41% | 7,104,022 | 11.32B |
| 89 | PEN | Penumbra, Inc. | 12.59B | 0.16% | 457,807 | 1.45B |
| 90 | ALGN | Align Technology, Inc. | 12.58B | 4.49% | 914,114 | 4.10B |
| 91 | RVTY | Revvity, Inc. | 12.44B | 3.18% | 1,772,609 | 2.90B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.42B | -2.26% | 218,772 | 1.13B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.08B | 0.29% | 1,694,969 | 622.01M |
| 94 | AXSM | Axsome Therapeutics, Inc. | 12.05B | -1.75% | 404,144 | 708.24M |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 12.00B | 2.99% | 1,942,198 | 3.24B |
| 96 | PODD | Insulet Corporation | 11.60B | 1.50% | 1,296,135 | 2.90B |
| 97 | CRL | Charles River Laboratories International, Inc. | 11.58B | 7.19% | 1,257,914 | 4.03B |
| 98 | EHC | Encompass Health Corporation | 11.51B | 1.89% | 866,076 | 6.07B |
| 99 | TECH | Bio-Techne Corporation | 11.23B | 0.63% | 7,785,768 | 1.21B |
| 100 | GMED | Globus Medical, Inc. | 10.94B | 2.98% | 989,347 | 3.10B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.79B | -1.45% | 1,659,988 | 105.82M |
| 102 | KRYS | Krystal Biotech, Inc. | 10.74B | 3.53% | 420,266 | 417.30M |
| 103 | ABVX | ABIVAX Société Anonyme | 10.69B | -2.95% | 1,016,699 | 5.67M |
| 104 | ENSG | The Ensign Group, Inc. | 10.58B | 2.85% | 705,742 | 5.49B |
| 105 | MOH | Molina Healthcare, Inc. | 10.44B | 0.43% | 1,540,799 | 42.47B |
| 106 | CORT | Corcept Therapeutics Incorporated | 10.11B | 3.37% | 823,417 | 769.10M |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.08% | 949,701 | - |
| 108 | UHS | Universal Health Services, Inc. | 10.06B | 4.34% | 2,106,862 | 18.11B |
| 109 | SMMT | Summit Therapeutics Inc. | 10.01B | -4.27% | 5,018,926 | - |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 9.90B | -0.34% | 4,137,493 | 3.50B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.90B | 2.41% | 2,623,608 | 1.51B |
| 112 | HSIC | Henry Schein, Inc. | 9.76B | 1.30% | 1,411,779 | 13.38B |
| 113 | BRKR | Bruker Corporation | 9.58B | 4.76% | 2,563,512 | 3.46B |
| 114 | OSCR | Oscar Health, Inc. | 9.46B | 10.80% | 7,417,188 | 13.30B |
| 115 | IONS | Ionis Pharmaceuticals, Inc. | 9.14B | -1.18% | 2,805,275 | 1.06B |
| 116 | GKOS | Glaukos Corporation | 8.88B | -0.38% | 1,144,674 | 551.35M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 8.86B | 4.61% | 592,281 | 2.59B |
| 118 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | 0.01% | 2,316,640 | 18.07M |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 8.80B | 0.94% | 282,383 | 74.06M |
| 120 | ATR | AptarGroup, Inc. | 8.80B | 3.33% | 593,148 | 3.87B |
| 121 | SYRE | Spyre Therapeutics, Inc. | 8.79B | -0.08% | 1,513,006 | - |
| 122 | QGEN | Qiagen N.V. | 8.74B | 2.92% | 2,031,354 | 2.10B |
| 123 | KYMR | Kymera Therapeutics, Inc. | 8.73B | -3.53% | 679,867 | 51.48M |
| 124 | AVTR | Avantor, Inc. | 8.48B | 5.61% | 20,344,046 | 6.55B |
| 125 | ALKS | Alkermes plc | 8.47B | -4.23% | 2,875,996 | 1.67B |
| 126 | HQY | HealthEquity, Inc. | 8.46B | 2.21% | 747,466 | 1.34B |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.25B | -6.33% | 438,617 | 7.46M |
| 128 | RGEN | Repligen Corporation | 8.20B | 10.90% | 2,508,131 | 785.10M |
| 129 | IMVT | Immunovant, Inc. | 8.03B | -2.97% | 897,628 | - |
| 130 | PCVX | Vaxcyte, Inc. | 7.88B | -1.62% | 1,301,555 | - |
| 131 | TGTX | TG Therapeutics, Inc. | 7.78B | -1.58% | 2,326,485 | 700.35M |
| 132 | TEM | Tempus AI, Inc. | 7.72B | -0.02% | 6,413,769 | 1.36B |
| 133 | LQDA | Liquidia Corporation | 7.72B | 2.84% | 1,168,004 | 288.07M |
| 134 | PACS | PACS Group, Inc. | 7.43B | -0.25% | 726,462 | 5.43B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.40B | 1.80% | 1,147,437 | 217.17M |
| 136 | IBRX | ImmunityBio, Inc. | 7.30B | -0.29% | 11,882,141 | 140.98M |
| 137 | COGT | Cogent Biosciences, Inc. | 6.95B | 0.57% | 1,133,725 | - |
| 138 | GRFS | Grifols, S.A. | 6.86B | 3.23% | 1,262,950 | 8.48B |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 6.84B | -1.73% | 437,935 | 569.61M |
| 140 | CHE | Chemed Corporation | 6.84B | 1.63% | 198,348 | 2.60B |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.79B | -3.04% | 12,836,946 | 2.37B |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.68B | -4.99% | 1,713,548 | 1.55B |
| 143 | CGON | CG Oncology, Inc. | 6.41B | -1.22% | 1,235,901 | 5.07M |
| 144 | ERAS | Erasca, Inc. | 6.30B | -3.76% | 3,816,829 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.28B | -1.28% | 485,022 | 7.50M |
| 146 | PTCT | PTC Therapeutics, Inc. | 6.25B | -0.54% | 1,487,693 | 827.11M |
| 147 | BLLN | BillionToOne, Inc. | 6.15B | 4.42% | 807,360 | 354.54M |
| 148 | BLTE | Belite Bio, Inc | 6.14B | -1.57% | 119,980 | - |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.11B | 25.03% | 2,874,898 | 840.85M |
| 150 | AMRX | Amneal Pharmaceuticals, Inc. | 5.98B | 3.70% | 1,765,196 | 3.05B |
| 151 | TXG | 10x Genomics, Inc. | 5.97B | 2.46% | 2,572,644 | 638.78M |
| 152 | TFX | Teleflex Incorporated | 5.94B | 2.40% | 360,417 | 2.13B |
| 153 | BLCO | Bausch + Lomb Corporation | 5.92B | 2.03% | 810,058 | 5.21B |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.92B | 0.90% | 943,848 | - |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | -0.41% | 353,456 | 274.48M |
| 156 | HNGE | Hinge Health, Inc. | 5.82B | 0.19% | 1,462,273 | 646.34M |
| 157 | DFTX | Definium Therapeutics, Inc. | 5.57B | -1.62% | 1,948,858 | - |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.55B | -2.76% | 841,023 | 1.34M |
| 159 | TWST | Twist Bioscience Corporation | 5.51B | 2.32% | 1,409,432 | 409.48M |
| 160 | STVN | Stevanato Group S.p.A. | 5.50B | 1.77% | 469,161 | 1.39B |
| 161 | ORKA | Oruka Therapeutics, Inc. | 5.46B | 0.28% | 766,577 | - |
| 162 | TVTX | Travere Therapeutics, Inc. | 5.20B | -1.36% | 1,117,640 | 536.20M |
| 163 | SHC | Sotera Health Company | 5.06B | 3.02% | 5,725,590 | 1.19B |
| 164 | INDV | Indivior Pharmaceuticals, Inc. | 5.00B | 2.40% | 1,778,429 | 1.29B |
| 165 | RDNT | RadNet, Inc. | 4.97B | 2.78% | 928,694 | 2.14B |
| 166 | MMED | MiniMed Group, Inc. | 4.95B | -0.17% | 1,757,520 | 3.10B |
| 167 | DYN | Dyne Therapeutics, Inc. | 4.83B | 1.05% | 2,334,667 | - |
| 168 | CRSP | CRISPR Therapeutics AG | 4.68B | 1.75% | 2,080,893 | 4.10M |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.67B | 2.88% | 840,350 | 1.54B |
| 170 | MANE | Veradermics, Incorporated | 4.66B | 0.11% | 988,278 | - |
| 171 | WAY | Waystar Holding Corp. | 4.54B | 2.42% | 2,516,992 | 1.16B |
| 172 | LIVN | LivaNova PLC | 4.51B | 1.87% | 536,787 | 1.43B |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | 2.44% | 940,900 | 1.10B |
| 174 | VCYT | Veracyte, Inc. | 4.44B | 0.07% | 740,194 | 541.74M |
| 175 | CAI | Caris Life Sciences, Inc. | 4.41B | -0.26% | 3,619,662 | 907.29M |
| 176 | NVST | Envista Holdings Corporation | 4.39B | 1.20% | 2,389,523 | 2.81B |
| 177 | LFST | LifeStance Health Group, Inc. | 4.36B | 3.31% | 2,114,691 | 1.49B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.34B | -3.00% | 964,369 | - |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.18B | 2.51% | 646,197 | 2.23B |
| 180 | ICUI | ICU Medical, Inc. | 4.14B | 2.67% | 240,228 | 2.16B |
| 181 | PBLS | Parabilis Medicines, Inc. | 4.07B | 0.44% | 360,859 | - |
| 182 | CELC | Celcuity Inc. | 4.02B | 0.23% | 1,962,110 | - |
| 183 | RLAY | Relay Therapeutics, Inc. | 3.99B | -1.88% | 2,933,296 | 10.68M |
| 184 | VKTX | Viking Therapeutics, Inc. | 3.93B | -2.90% | 2,330,923 | - |
| 185 | IRTC | iRhythm Holdings, Inc. | 3.86B | 4.65% | 492,699 | 787.85M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.85B | -0.26% | 6,566,622 | 56.99M |
| 187 | DOCS | Doximity, Inc. | 3.85B | 2.14% | 4,202,617 | 644.86M |
| 188 | DNLI | Denali Therapeutics Inc. | 3.82B | 2.04% | 2,106,287 | - |
| 189 | ALHC | Alignment Healthcare, Inc. | 3.81B | -1.29% | 5,901,562 | 4.26B |
| 190 | ELVN | Enliven Therapeutics, Inc. | 3.75B | 1.93% | 727,219 | - |
| 191 | HAE | Haemonetics Corporation | 3.75B | 3.29% | 803,457 | 1.33B |
| 192 | LEGN | Legend Biotech Corporation | 3.68B | -1.19% | 3,993,107 | 1.14B |
| 193 | BKD | Brookdale Senior Living Inc. | 3.67B | -0.65% | 4,629,866 | 3.00B |
| 194 | NHC | National HealthCare Corporation | 3.61B | 2.17% | 65,374 | 1.53B |
| 195 | ADPT | Adaptive Biotechnologies Corporation | 3.60B | -0.09% | 1,678,937 | 295.41M |
| 196 | ARQT | Arcutis Biotherapeutics, Inc. | 3.55B | 2.08% | 1,066,060 | 415.62M |
| 197 | OGN | Organon & Co. | 3.55B | -0.15% | 2,330,090 | 6.16B |
| 198 | OPCH | Option Care Health, Inc. | 3.53B | 3.07% | 4,112,819 | 5.67B |
| 199 | ALMS | Alumis Inc. | 3.45B | -0.18% | 782,565 | 8.40M |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.44B | -1.66% | 655,270 | 225.27M |
| 201 | TLX | Telix Pharmaceuticals Limited | 3.44B | 2.10% | 67,267 | 803.79M |
| 202 | ITGR | Integer Holdings Corporation | 3.41B | 0.99% | 522,455 | 1.86B |
| 203 | GPCR | Structure Therapeutics Inc. | 3.40B | -1.64% | 507,631 | - |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.40B | -2.84% | 1,580,324 | 236.00M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | -7.41% | 890,487 | 22.57M |
| 206 | WRBY | Warby Parker Inc. | 3.19B | 4.59% | 2,508,906 | 890.57M |
| 207 | PRVA | Privia Health Group, Inc. | 3.13B | 0.65% | 1,149,931 | 2.25B |
| 208 | ACHC | Acadia Healthcare Company, Inc. | 3.01B | 0.58% | 4,345,583 | 3.37B |
| 209 | RGC | Regencell Bioscience Holdings Limited | 2.96B | 2.40% | 164,102 | - |
| 210 | MBX | MBX Biosciences, Inc. | 2.86B | -2.02% | 625,724 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.85B | 0.05% | 448,199 | - |
| 212 | CLDX | Celldex Therapeutics, Inc. | 2.79B | -0.20% | 565,896 | 865.00K |
| 213 | SUPN | Supernus Pharmaceuticals, Inc. | 2.77B | 1.60% | 538,195 | 776.83M |
| 214 | GRAL | GRAIL, Inc. | 2.76B | -3.52% | 789,904 | 156.12M |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.70B | -0.22% | 393,025 | 229.58M |
| 216 | XRAY | DENTSPLY SIRONA Inc. | 2.70B | 3.61% | 4,794,994 | 3.68B |
| 217 | ATAI | AtaiBeckley Inc. | 2.66B | 0.14% | 17,244,382 | 3.49M |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.65B | 0.96% | 201,093 | 1.46B |
| 219 | TMDX | TransMedics Group, Inc. | 2.64B | 2.71% | 768,598 | 635.89M |
| 220 | IMNM | Immunome, Inc. | 2.63B | 2.83% | 861,681 | 4.02M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.62B | 4.87% | 2,298,014 | 164.01M |
| 222 | TRVI | Trevi Therapeutics, Inc. | 2.62B | 1.71% | 1,666,974 | - |
| 223 | RARE | Ultragenyx Pharmaceutical Inc. | 2.55B | -3.38% | 1,844,369 | 670.00M |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -1.95% | 510,220 | 535.08M |
| 225 | QURE | uniQure N.V. | 2.52B | -4.06% | 3,011,614 | 18.09M |
| 226 | KOD | Kodiak Sciences Inc. | 2.52B | -3.87% | 754,805 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.51B | 3.07% | 1,148,039 | 36.77M |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | 1.67% | 2,875,376 | 885.72M |
| 229 | PLSE | Pulse Biosciences, Inc. | 2.45B | 8.17% | 684,997 | 751.00K |
| 230 | PBH | Prestige Consumer Healthcare Inc. | 2.45B | 2.62% | 439,538 | 1.09B |
| 231 | PGNY | Progyny, Inc. | 2.41B | -2.63% | 1,735,958 | 1.29B |
| 232 | VERA | Vera Therapeutics, Inc. | 2.39B | -5.29% | 3,021,476 | - |
| 233 | NKTR | Nektar Therapeutics | 2.39B | -0.81% | 713,186 | 55.63M |
| 234 | VCEL | Vericel Corporation | 2.39B | 3.07% | 433,574 | 292.09M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -0.96% | 564,766 | - |
| 236 | PHVS | Pharvaris N.V. | 2.35B | -0.96% | 205,062 | - |
| 237 | LMAT | LeMaitre Vascular, Inc. | 2.34B | 3.41% | 317,870 | 256.28M |
| 238 | NUVB | Nuvation Bio Inc. | 2.33B | 0.45% | 5,383,343 | 143.05M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.28B | 1.52% | 3,845,268 | 2.21B |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.21B | -6.21% | 430,568 | - |
| 241 | HTFL | HeartFlow, Inc. | 2.21B | 0.87% | 1,489,377 | 191.42M |
| 242 | AXGN | Axogen, Inc. | 2.19B | 0.02% | 1,365,319 | 238.11M |
| 243 | ADUS | Addus HomeCare Corporation | 2.18B | 3.09% | 196,090 | 1.45B |
| 244 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.17B | 0.31% | 3,410,857 | -665.00K |
| 245 | KLRA | Kailera Therapeutics, Inc. | 2.17B | -4.23% | 539,525 | - |
| 246 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -0.96% | 1,101,099 | 70.92M |
| 247 | MD | Pediatrix Medical Group, Inc. | 2.15B | 2.75% | 506,159 | 1.93B |
| 248 | AVAH | Aveanna Healthcare Holdings Inc. | 2.15B | 2.28% | 1,555,912 | 2.52B |
| 249 | AGIO | Agios Pharmaceuticals, Inc. | 2.14B | -2.65% | 834,946 | 66.05M |
| 250 | SION | Sionna Therapeutics, Inc. | 2.10B | 2.58% | 320,289 | - |
| 251 | IOVA | Iovance Biotherapeutics, Inc. | 2.10B | -4.08% | 13,441,679 | 285.61M |
| 252 | ZLAB | Zai Lab Limited | 2.09B | -0.11% | 1,136,501 | 453.28M |
| 253 | BHVN | Biohaven Ltd. | 2.07B | -5.10% | 3,625,683 | - |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 2.07B | -0.67% | 886,123 | 899.11M |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.05B | 0.75% | 148,637 | - |
| 256 | ZBIO | Zenas BioPharma, Inc. | 2.04B | -1.61% | 773,849 | 10.00M |
| 257 | ADMA | ADMA Biologics, Inc. | 2.04B | 3.66% | 2,171,987 | 509.86M |
| 258 | ATRC | AtriCure, Inc. | 2.02B | 6.37% | 1,071,500 | 569.62M |
| 259 | SGRY | Surgery Partners, Inc. | 2.02B | 2.70% | 1,658,311 | 3.34B |
| 260 | HCM | HUTCHMED (China) Limited | 2.02B | 0.72% | 27,728 | 548.51M |
| 261 | SNDA | Sonida Senior Living, Inc. | 2.01B | 0.58% | 629,235 | 367.34M |
| 262 | RAPP | Rapport Therapeutics, Inc. | 2.01B | -0.40% | 353,981 | 20.00M |
| 263 | NEOG | Neogen Corporation | 2.00B | -1.61% | 2,485,301 | 870.56M |
| 264 | UFPT | UFP Technologies, Inc. | 2.00B | 3.80% | 254,776 | 608.85M |
| 265 | URGN | UroGen Pharma Ltd. | 1.99B | -1.40% | 390,951 | 140.49M |
| 266 | SLS | SELLAS Life Sciences Group, Inc. | 1.98B | -6.88% | 10,168,594 | - |
| 267 | PGEN | Precigen, Inc. | 1.97B | 2.03% | 3,760,531 | 31.60M |
| 268 | FTRE | Fortrea Holdings Inc. | 1.96B | 7.81% | 3,238,258 | 2.71B |
| 269 | OMCL | Omnicell, Inc. | 1.96B | 3.76% | 753,773 | 1.23B |
| 270 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | -1.71% | 1,712,728 | 298.30M |
| 271 | GHRS | GH Research PLC | 1.92B | 0.76% | 202,161 | - |
| 272 | NVCR | NovoCure Limited | 1.90B | -4.23% | 1,383,902 | 699.19M |
| 273 | NBTX | Nanobiotix S.A. | 1.90B | -5.87% | 126,737 | 38.27M |
| 274 | BFLY | Butterfly Network, Inc. | 1.88B | 1.41% | 4,296,516 | 102.92M |
| 275 | KARD | Kardigan, Inc. | 1.88B | -1.13% | 144,492 | - |
| 276 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.20% | 2,571,080 | - |
| 277 | MESO | Mesoblast Limited | 1.87B | -0.76% | 209,621 | 65.38M |
| 278 | GLUE | Monte Rosa Therapeutics, Inc. | 1.86B | -2.30% | 1,329,706 | 42.95M |
| 279 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.07% | 126,807 | 1.20B |
| 280 | OCUL | Ocular Therapeutix, Inc. | 1.85B | -2.20% | 2,373,435 | 52.04M |
| 281 | CDNA | CareDx, Inc. | 1.85B | -1.68% | 939,403 | 412.82M |
| 282 | WGS | GeneDx Holdings Corp. | 1.84B | 2.21% | 714,553 | 442.68M |
| 283 | TYRA | Tyra Biosciences, Inc. | 1.84B | -0.58% | 410,198 | - |
| 284 | STOK | Stoke Therapeutics, Inc. | 1.83B | 0.27% | 598,353 | 32.08M |
| 285 | DMRA | Damora Therapeutics, Inc. | 1.81B | -0.07% | 305,472 | - |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.77B | 2.54% | 2,412,773 | 204.73M |
| 287 | BCAX | Bicara Therapeutics Inc. | 1.77B | -3.34% | 489,919 | - |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.75B | -1.44% | 2,560,489 | 7.47M |
| 289 | NEO | NeoGenomics, Inc. | 1.74B | 1.98% | 2,402,644 | 766.30M |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -4.34% | 939,067 | 217.17M |
| 291 | ANIP | ANI Pharmaceuticals, Inc. | 1.72B | 3.41% | 219,651 | 923.71M |
| 292 | ALMR | Alamar Biosciences, Inc. | 1.71B | 1.27% | 190,640 | 87.16M |
| 293 | ASTH | Astrana Health, Inc. | 1.71B | -0.58% | 647,029 | 3.53B |
| 294 | IMCR | Immunocore Holdings plc | 1.70B | -0.77% | 207,249 | 412.81M |
| 295 | ENOV | Enovis Corporation | 1.70B | 4.50% | 1,301,951 | 2.28B |
| 296 | TDOC | Teladoc Health, Inc. | 1.69B | 5.05% | 4,873,524 | 2.51B |
| 297 | BHC | Bausch Health Companies Inc. | 1.69B | 0.89% | 1,294,891 | 10.53B |
| 298 | GENB | Generate Biomedicines, Inc. | 1.68B | -3.95% | 1,457,828 | 30.30M |
| 299 | AAPG | Ascentage Pharma Group International | 1.65B | -3.20% | 4,674 | 82.08M |
| 300 | AGL | agilon health, inc. | 1.65B | 0.72% | 406,298 | 5.82B |
| 301 | ARDT | Ardent Health, Inc. | 1.64B | 4.75% | 608,225 | 6.43B |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.63B | 3.49% | 1,047,976 | 1.86B |
| 303 | SRPT | Sarepta Therapeutics, Inc. | 1.63B | -2.89% | 3,533,427 | 2.18B |
| 304 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | 1.33% | 24,398,106 | 66.41M |
| 305 | ZYME | Zymeworks Inc. | 1.62B | -1.70% | 358,041 | 81.26M |
| 306 | ABCL | AbCellera Biologics Inc. | 1.62B | 0.76% | 6,082,225 | 79.21M |
| 307 | INVA | Innoviva, Inc. | 1.61B | 2.39% | 605,770 | 420.69M |
| 308 | INNV | InnovAge Holding Corp. | 1.60B | 2.87% | 295,560 | 949.17M |
| 309 | TRLV | Trulieve Cannabis Corp. | 1.60B | - | 787,412 | 1.17B |
| 310 | BLFS | BioLife Solutions, Inc. | 1.56B | 7.35% | 2,710,850 | 101.66M |
| 311 | MLTX | MoonLake Immunotherapeutics | 1.55B | -5.89% | 1,051,691 | - |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.54B | -2.82% | 383,127 | 20.00M |
| 313 | ANAB | AnaptysBio, Inc. | 1.54B | -2.80% | 522,762 | 232.39M |
| 314 | IART | Integra LifeSciences Holdings Corporation | 1.54B | 1.18% | 1,166,340 | 1.64B |
| 315 | SEPN | Septerna, Inc. | 1.53B | 1.43% | 263,369 | 72.26M |
| 316 | NTLA | Intellia Therapeutics, Inc. | 1.52B | 2.06% | 4,859,992 | 66.09M |
| 317 | INSP | Inspire Medical Systems, Inc. | 1.50B | 2.04% | 935,062 | 915.25M |
| 318 | AHCO | AdaptHealth Corp. | 1.49B | 2.37% | 771,748 | 3.29B |
| 319 | XERS | Xeris Biopharma Holdings, Inc. | 1.49B | 0.37% | 811,644 | 314.85M |
| 320 | VIR | Vir Biotechnology, Inc. | 1.49B | 0.57% | 1,391,470 | 65.50M |
| 321 | XNCR | Xencor, Inc. | 1.48B | 0.55% | 845,863 | 97.36M |
| 322 | PAHC | Phibro Animal Health Corporation | 1.48B | 3.21% | 399,159 | 1.50B |
| 323 | HROW | Harrow, Inc. | 1.47B | 4.97% | 569,629 | 268.68M |
| 324 | CMPS | COMPASS Pathways plc | 1.46B | -3.73% | 2,670,644 | - |
| 325 | PNTG | The Pennant Group, Inc. | 1.46B | 1.64% | 266,868 | 1.02B |
| 326 | TRAX | First Tracks Biotherapeutics, Inc. | 1.46B | -0.43% | 761,316 | - |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.43B | 7.50% | 2,082,196 | 787.08M |
| 328 | PRGO | Perrigo Company plc | 1.43B | 1.58% | 2,700,857 | 4.18B |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.40B | 4.56% | 451,355 | 95.13M |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.40B | -0.60% | 818,430 | - |
| 331 | SVRA | Savara Inc. | 1.35B | -1.84% | 1,679,270 | - |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.35B | 3.71% | 464,449 | 3.42B |
| 333 | AZTA | Azenta, Inc. | 1.33B | 5.12% | 655,215 | 596.48M |
| 334 | CNMD | CONMED Corporation | 1.33B | 1.70% | 762,796 | 1.37B |
| 335 | AORT | Artivion, Inc. | 1.31B | 3.49% | 510,730 | 458.69M |
| 336 | ETON | Eton Pharmaceuticals, Inc. | 1.28B | 10.28% | 891,270 | 86.93M |
| 337 | AKTS | Aktis Oncology, Inc. | 1.27B | -5.12% | 312,225 | 8.28M |
| 338 | ARDX | Ardelyx, Inc. | 1.26B | 0.49% | 1,655,743 | 427.68M |
| 339 | AHG | Akso Health Group | 1.25B | - | - | 13.83M |
| 340 | PSNL | Personalis, Inc. | 1.24B | -0.83% | 2,809,594 | 64.52M |
| 341 | ORIC | ORIC Pharmaceuticals, Inc. | 1.23B | -0.92% | 1,144,803 | - |
| 342 | AVLN | Avalyn Pharma Inc. | 1.23B | 0.62% | 186,843 | - |
| 343 | OPK | OPKO Health, Inc. | 1.23B | 33.06% | 34,590,180 | 587.90M |
| 344 | CERT | Certara, Inc. | 1.23B | 2.06% | 5,055,920 | 419.75M |
| 345 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | 3.44% | 1,860,966 | 1.03B |
| 346 | FRNM | Freenome, Inc. | 1.22B | -5.36% | 759,926 | 34.24M |
| 347 | OMDA | Omada Health, Inc. | 1.21B | -0.73% | 2,197,833 | 283.30M |
| 348 | IRMD | IRADIMED CORPORATION | 1.21B | -0.26% | 113,776 | 86.28M |
| 349 | NVAX | Novavax, Inc. | 1.21B | -1.60% | 2,869,431 | 596.34M |
| 350 | MNKD | MannKind Corporation | 1.21B | -1.01% | 3,657,168 | 360.78M |
| 351 | ABSI | Absci Corporation | 1.21B | -5.69% | 2,874,716 | 1.84M |
| 352 | USPH | U.S. Physical Therapy, Inc. | 1.20B | 3.08% | 205,578 | 787.69M |
| 353 | IMTX | Immatics N.V. | 1.19B | 1.22% | 535,040 | 43.00M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.17B | -1.25% | 775,731 | - |
| 355 | INBX | Inhibrx Biosciences, Inc. | 1.17B | -3.36% | 185,902 | 1.30M |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | 1.07% | 225,604 | 796.33M |
| 357 | SDGR | Schrödinger, Inc. | 1.14B | 0.07% | 539,178 | 254.91M |
| 358 | QDEL | QuidelOrtho Corporation | 1.14B | -0.95% | 989,724 | 2.66B |
| 359 | WVE | Wave Life Sciences Ltd. | 1.13B | -0.51% | 2,812,265 | 71.80M |
| 360 | STAA | STAAR Surgical Company | 1.13B | -1.26% | 1,116,850 | 290.38M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | 3.02% | 839,074 | - |
| 362 | ALVO | Alvotech | 1.11B | 0.65% | 330,587 | 562.04M |
| 363 | BVS | Bioventus Inc. | 1.10B | 6.10% | 956,065 | 576.30M |
| 364 | MGTX | MeiraGTx Holdings plc | 1.09B | -3.90% | 460,782 | 79.76M |
| 365 | VOR | Vor Biopharma Inc. | 1.08B | 2.88% | 864,936 | - |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | 0.23% | 572,145 | - |
| 367 | ANRO | Alto Neuroscience, Inc. | 1.07B | -1.61% | 410,767 | - |
| 368 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -3.12% | 75,297 | - |
| 369 | CRON | Cronos Group Inc. | 1.06B | -0.35% | 828,156 | 159.54M |
| 370 | IVA | Inventiva S.A. | 1.06B | 0.87% | 928,291 | 7.94M |
| 371 | GDRX | GoodRx Holdings, Inc. | 1.06B | 2.30% | 789,067 | 787.89M |
| 372 | PCRX | Pacira BioSciences, Inc. | 1.05B | 1.28% | 466,074 | 734.86M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.05B | -0.72% | 360,878 | 1.03B |
| 374 | DRTS | Alpha Tau Medical Ltd. | 1.04B | -5.41% | 909,386 | - |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 4.93% | 2,680,220 | 69.64M |
| 376 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 0.10% | 815,719 | 59.00K |
| 377 | PRCT | PROCEPT BioRobotics Corporation | 1.03B | 2.20% | 1,581,561 | 322.02M |
| 378 | NUTX | Nutex Health Inc. | 1.03B | 0.22% | 119,906 | 879.95M |
| 379 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | -3.25% | 1,165,678 | - |
| 380 | GMRS | GMR Solutions Inc. | 1.01B | 2.20% | 431,551 | 5.83B |
| 381 | EYPT | EyePoint, Inc. | 1.00B | -3.63% | 1,698,346 | 7.61M |
| 382 | LBRX | LB Pharmaceuticals Inc | 1.00B | 0.46% | 290,610 | - |
| 383 | SANA | Sana Biotechnology, Inc. | 986.67M | 0.30% | 3,653,151 | - |
| 384 | BIOA | BioAge Labs, Inc. | 974.40M | 4.98% | 597,566 | 10.32M |
| 385 | GERN | Geron Corporation | 930.21M | -2.03% | 5,043,309 | 196.12M |
| 386 | PHAT | Phathom Pharmaceuticals, Inc. | 926.15M | -2.43% | 689,282 | 204.89M |
| 387 | JANX | Janux Therapeutics, Inc. | 914.77M | -3.66% | 684,783 | 13.73M |
| 388 | INMD | InMode Ltd. | 889.23M | 0.59% | 586,146 | 374.64M |
| 389 | AMPH | Amphastar Pharmaceuticals, Inc. | 888.47M | 5.06% | 390,837 | 720.53M |
| 390 | PHAR | Pharming Group N.V. | 885.23M | -1.15% | 4,237 | 369.49M |
| 391 | ODTX | Odyssey Therapeutics, Inc. | 882.39M | -3.15% | 144,034 | 1.06M |
| 392 | TBPH | Theravance Biopharma, Inc. | 875.38M | 0.18% | 257,586 | 109.78M |
| 393 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,081,298 | 238.37M |
| 394 | ABUS | Arbutus Biopharma Corporation | 871.14M | - | 633,620 | 191.45M |
| 395 | HSTM | HealthStream, Inc. | 842.86M | 3.52% | 173,832 | 311.78M |
| 396 | GLAS | Glass House Brands Inc. | 841.39M | -2.27% | 312,364 | 177.68M |
| 397 | KURA | Kura Oncology, Inc. | 826.49M | -8.28% | 1,482,978 | 71.64M |
| 398 | OMER | Omeros Corporation | 816.39M | -0.53% | 2,222,452 | 9.89M |
| 399 | ANNX | Annexon, Inc. | 814.30M | -3.12% | 2,495,623 | - |
| 400 | TENX | Tenax Therapeutics, Inc. | 807.25M | -2.41% | 1,560,345 | - |
| 401 | DBVT | DBV Technologies S.A. | 799.81M | -2.88% | 365,973 | 5.04M |
| 402 | AVR | Anteris Technologies Global Corp. | 796.21M | - | 1,504,796 | 1.85M |
| 403 | SIBN | SI-BONE, Inc. | 795.18M | 5.16% | 704,892 | 206.22M |
| 404 | SSII | SS Innovations International, Inc. | 786.52M | -0.76% | 109,247 | 48.47M |
| 405 | SLDB | Solid Biosciences Inc. | 784.64M | 1.01% | 1,235,110 | - |
| 406 | AURA | Aura Biosciences, Inc. | 777.61M | -1.54% | 439,329 | - |
| 407 | FTH | Faeth Therapeutics, Inc. | 750.94M | -0.38% | 299,314 | - |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 744.41M | -0.74% | 1,552,981 | 8.37M |
| 409 | DSGN | Design Therapeutics, Inc. | 741.36M | -0.08% | 489,104 | - |
| 410 | MNPR | Monopar Therapeutics Inc. | 730.77M | -1.12% | 528,971 | - |
| 411 | CSTL | Castle Biosciences, Inc. | 724.58M | -2.25% | 366,214 | 339.92M |
| 412 | SGP | SpyGlass Pharma, Inc. | 722.83M | 3.84% | 69,790 | - |
| 413 | RIGL | Rigel Pharmaceuticals, Inc. | 712.33M | 2.97% | 142,577 | 299.77M |
| 414 | EVO | Evotec SE | 709.70M | 2.08% | 50,289 | 859.03M |
| 415 | CADL | Candel Therapeutics, Inc. | 709.26M | -2.81% | 1,667,318 | - |
| 416 | DRUG | Bright Minds Biosciences Inc. | 704.79M | 0.07% | 238,522 | - |
| 417 | BBNX | Beta Bionics, Inc. | 704.07M | -1.19% | 660,159 | 110.24M |
| 418 | CLYM | Climb Bio, Inc. | 703.73M | -3.91% | 953,280 | - |
| 419 | CTMX | CytomX Therapeutics, Inc. | 701.00M | -0.92% | 2,007,574 | 35.54M |
| 420 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 688.12M | -1.83% | 129,180 | - |
| 421 | CBIO | Crescent Biopharma, Inc. | 679.36M | -2.89% | 233,809 | 11.88M |
| 422 | CBLL | CeriBell, Inc. | 676.52M | -1.65% | 311,418 | 95.07M |
| 423 | PHR | Phreesia, Inc. | 671.28M | 2.16% | 703,534 | 495.59M |
| 424 | GYRE | Gyre Therapeutics, Inc. | 667.82M | -2.28% | 31,880 | 117.05M |
| 425 | OCS | Oculis Holding AG | 667.59M | 0.32% | 435,869 | 1.40M |
| 426 | NGNE | Neurogene Inc. | 661.97M | -4.04% | 157,413 | 925.00K |
| 427 | MDXG | MiMedx Group, Inc. | 649.40M | 2.35% | 1,119,392 | 389.42M |
| 428 | ACHV | Achieve Life Sciences, Inc. | 634.43M | - | 1,304,741 | - |
| 429 | TCMD | Tactile Systems Technology, Inc. | 625.71M | -0.07% | 299,305 | 343.52M |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 625.53M | -2.81% | 1,821,245 | 361.51M |
| 431 | NVCT | Nuvectis Pharma, Inc. | 624.84M | 1.43% | 195,511 | - |
| 432 | BWAY | BrainsWay Ltd. | 620.31M | -1.71% | 98,845 | 56.22M |
| 433 | AGMB | AgomAb Therapeutics NV | 617.57M | 0.24% | 33,032 | - |
| 434 | IMMX | Immix Biopharma, Inc. | 600.84M | -2.88% | 1,686,340 | - |
| 435 | ANGO | AngioDynamics, Inc. | 592.71M | 4.98% | 514,829 | 320.17M |
| 436 | RGNX | REGENXBIO Inc. | 592.35M | -1.13% | 1,389,866 | 87.82M |
| 437 | CERS | Cerus Corporation | 585.08M | -4.89% | 1,623,809 | 216.56M |
| 438 | ALT | Altimmune, Inc. | 581.48M | 1.01% | 17,142,615 | 36.00K |
| 439 | CRMD | CorMedix Inc. | 576.62M | -3.29% | 1,251,835 | 400.05M |
| 440 | CTKB | Cytek Biosciences, Inc. | 575.98M | 1.13% | 713,041 | 204.17M |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 575.19M | 0.21% | 1,505,119 | 122.29M |
| 442 | ALLO | Allogene Therapeutics, Inc. | 572.96M | -5.14% | 9,960,229 | 22.00K |
| 443 | SPRY | ARS Pharmaceuticals, Inc. | 563.05M | -1.56% | 1,353,862 | 98.99M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 562.30M | -2.65% | 146,348 | - |
| 445 | MPLT | MapLight Therapeutics, Inc. | 558.21M | 24.28% | 5,546,204 | - |
| 446 | PRME | Prime Medicine, Inc. | 558.11M | 2.66% | 3,096,534 | 4.03M |
| 447 | FLGT | Fulgent Genetics, Inc. | 557.50M | 0.26% | 260,083 | 320.35M |
| 448 | RLMD | Relmada Therapeutics, Inc. | 548.58M | 0.58% | 1,514,913 | - |
| 449 | WEAV | Weave Communications, Inc. | 548.21M | 3.61% | 930,156 | 248.72M |
| 450 | VSTM | Verastem, Inc. | 547.45M | 2.47% | 1,275,020 | 49.59M |
| 451 | SLN | Silence Therapeutics plc | 545.55M | -4.31% | 1,190,812 | 839.00K |
| 452 | CTNM | Contineum Therapeutics, Inc. | 529.39M | 2.16% | 210,883 | - |
| 453 | ARVN | Arvinas, Inc. | 529.07M | -0.24% | 551,915 | 89.40M |
| 454 | ZURA | Zura Bio Limited | 526.29M | 2.97% | 504,849 | - |
| 455 | STTK | Shattuck Labs, Inc. | 522.96M | -3.12% | 764,885 | 1.00M |
| 456 | NPCE | NeuroPace, Inc. | 521.98M | 0.07% | 154,722 | 99.53M |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 514.92M | -5.11% | 628,850 | 88.24M |
| 458 | RZLT | Rezolute, Inc. | 513.98M | -0.40% | 980,119 | - |
| 459 | EIKN | Eikon Therapeutics, Inc. | 513.78M | -3.95% | 216,433 | - |
| 460 | ARTV | Artiva Biotherapeutics, Inc. | 511.63M | 2.03% | 357,938 | 251.00K |
| 461 | KIDS | OrthoPediatrics Corp. | 509.59M | 0.10% | 151,743 | 243.30M |
| 462 | ANL | Adlai Nortye Ltd. | 507.60M | 5.22% | 201,377 | 5.00M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 464 | NRC | NRC Health | 503.47M | 5.03% | 112,445 | 140.00M |
| 465 | DNA | Ginkgo Bioworks Holdings, Inc. | 503.00M | 3.36% | 834,223 | 151.40M |
| 466 | SI | Shoulder Innovations, Inc. | 502.90M | 15.70% | 144,302 | 53.89M |
| 467 | MYGN | Myriad Genetics, Inc. | 502.46M | -2.39% | 1,164,946 | 829.00M |
| 468 | OFIX | Orthofix Medical Inc. | 495.57M | 3.03% | 268,326 | 825.37M |
| 469 | TOI | The Oncology Institute, Inc. | 494.92M | -4.62% | 2,380,057 | 545.76M |
| 470 | ASMB | Assembly Biosciences, Inc. | 492.25M | -1.31% | 86,408 | 71.10M |
| 471 | TLRY | Tilray Brands, Inc. | 480.71M | - | 5,144,247 | 915.45M |
| 472 | VALN | Valneva SE | 473.69M | 2.02% | 6,347 | 180.25M |
| 473 | AQST | Aquestive Therapeutics, Inc. | 471.76M | 0.80% | 2,820,716 | 50.27M |
| 474 | HELP | Cybin Inc. | 471.08M | -1.30% | 861,172 | - |
| 475 | VREX | Varex Imaging Corporation | 469.09M | 1.37% | 267,907 | 857.50M |
| 476 | SOPH | SOPHiA GENETICS SA | 467.30M | -1.42% | 154,943 | 81.18M |
| 477 | PROK | ProKidney Corp. | 465.17M | - | 788,165 | 889.00K |
| 478 | PRLD | Prelude Therapeutics Incorporated | 460.18M | 19.28% | 1,859,004 | 16.72M |
| 479 | VMD | Viemed Healthcare, Inc. | 456.97M | -1.65% | 198,405 | 286.57M |
| 480 | KYTX | Kyverna Therapeutics, Inc. | 455.36M | -5.43% | 1,067,516 | - |
| 481 | IKT | Inhibikase Therapeutics, Inc. | 451.43M | -1.70% | 472,198 | 1.00 |
| 482 | REPL | Replimune Group, Inc. | 449.21M | -38.01% | 24,020,461 | - |
| 483 | SGMT | Sagimet Biosciences Inc. | 448.94M | -2.42% | 392,621 | - |
| 484 | PRTA | Prothena Corporation plc | 448.14M | -1.61% | 802,256 | 57.94M |
| 485 | NNNN | Anbio Biotechnology | 445.50M | -0.29% | 30,587 | 8.65M |
| 486 | CABA | Cabaletta Bio, Inc. | 445.14M | 0.37% | 1,889,284 | - |
| 487 | SLBT | SL Science Holding Limited | 444.47M | -0.36% | 38,285 | 3.36M |
| 488 | OVID | Ovid Therapeutics Inc. | 440.47M | 0.43% | 1,351,125 | 7.12M |
| 489 | SRTA | Strata Critical Medical, Inc. | 440.42M | -0.97% | 773,009 | 228.58M |
| 490 | CLPT | ClearPoint Neuro, Inc. | 435.75M | -0.48% | 663,918 | 40.61M |
| 491 | PACB | Pacific Biosciences of California, Inc. | 431.74M | 2.21% | 7,931,231 | 160.03M |
| 492 | EVH | Evolent Health, Inc. | 420.68M | -1.84% | 7,575,497 | 1.89B |
| 493 | OCGN | Ocugen, Inc. | 419.77M | -1.59% | 4,879,005 | 4.47M |
| 494 | EOLS | Evolus, Inc. | 409.62M | 0.65% | 599,640 | 301.79M |
| 495 | BNTC | Benitec Biopharma Inc. | 408.47M | 2.68% | 77,900 | - |
| 496 | PBYI | Puma Biotechnology, Inc. | 405.67M | -0.25% | 310,490 | 227.18M |
| 497 | EVMN | Evommune, Inc. | 405.21M | -1.92% | 699,448 | 10.00M |
| 498 | EDIT | Editas Medicine, Inc. | 402.07M | -2.24% | 1,464,407 | 38.69M |
| 499 | LRMR | Larimar Therapeutics, Inc. | 399.79M | - | 1,778,866 | - |
| 500 | KMDA | Kamada Ltd. | 399.60M | 1.00% | 78,442 | 181.68M |